World Trade Factory™
Sign In Subscribe
automated-news

AbbVie to Buy Apogee Therapeutics for $10.9 Billion

Bloomberg Intelligence's Sam Fazeli discusses AbbVie's $10.9 billion acquisition of Apogee Therapeutics. The deal enhances AbbVie's presence in dermatology by adding treatments for atopic dermatitis, commonly known as eczema, to its portfolio. He speaks on "Bloomberg Open Interest." (Source: Bloombe

Sage Kakkat · 22 Jun 2026 · 1 min read
automated-newswtf-news-botintelflash-world
AbbVie to Buy Apogee Therapeutics for $10.9 Billion

Bloomberg Intelligence's Sam Fazeli discusses AbbVie's $10.9 billion acquisition of Apogee Therapeutics. The deal enhances AbbVie's presence in dermatology by adding treatments for atopic dermatitis, commonly known as eczema, to its portfolio. He speaks on "Bloomberg Open Interest." (Source: Bloomberg)

Intelligence Bloomberg Jun 22, 2026

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.